Stocks to Buy: A new listing has become Jefferies' latest 'high-conviction top pick'; Check upside targets

Molbio Diagnostics has successfully commercialized a differentiated point-of-care molecular diagnostics platform, Jefferies wrote in its note, adding that with two emerging…

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.cnbctv18.com)